322 related articles for article (PubMed ID: 25838542)
1. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.
Kouri FM; Hurley LA; Daniel WL; Day ES; Hua Y; Hao L; Peng CY; Merkel TJ; Queisser MA; Ritner C; Zhang H; James CD; Sznajder JI; Chin L; Giljohann DA; Kessler JA; Peter ME; Mirkin CA; Stegh AH
Genes Dev; 2015 Apr; 29(7):732-45. PubMed ID: 25838542
[TBL] [Abstract][Full Text] [Related]
2. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
Kouri FM; Ritner C; Stegh AH
Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
[TBL] [Abstract][Full Text] [Related]
3. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
[TBL] [Abstract][Full Text] [Related]
4. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
[TBL] [Abstract][Full Text] [Related]
5. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
7. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
Kumthekar P; Ko CH; Paunesku T; Dixit K; Sonabend AM; Bloch O; Tate M; Schwartz M; Zuckerman L; Lezon R; Lukas RV; Jovanovic B; McCortney K; Colman H; Chen S; Lai B; Antipova O; Deng J; Li L; Tommasini-Ghelfi S; Hurley LA; Unruh D; Sharma NV; Kandpal M; Kouri FM; Davuluri RV; Brat DJ; Muzzio M; Glass M; Vijayakumar V; Heidel J; Giles FJ; Adams AK; James CD; Woloschak GE; Horbinski C; Stegh AH
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692132
[TBL] [Abstract][Full Text] [Related]
8. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
Lan F; Yu H; Hu M; Xia T; Yue X
J Neurochem; 2015 Oct; 135(2):274-86. PubMed ID: 26250785
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
10. Chemo-resistance of A172 glioblastoma cells is controlled by miR-1271-regulated Bcl-2.
Yang L; Wang Y; Li YJ; Zeng CC
Biomed Pharmacother; 2018 Dec; 108():734-740. PubMed ID: 30248541
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
12. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
13. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-640 Inhibition Enhances the Chemosensitivity of Human Glioblastoma Cells to Temozolomide by Targeting Bcl2 Modifying Factor.
Jiang S; Luo C; Chen Y; Chen J; Tao S; Zou Q; He C; Dong S
Biochem Genet; 2023 Apr; 61(2):538-550. PubMed ID: 35984538
[TBL] [Abstract][Full Text] [Related]
15. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
[TBL] [Abstract][Full Text] [Related]
16. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
17. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.
El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM
Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089
[TBL] [Abstract][Full Text] [Related]
18. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
19. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
Peng Y; He X; Chen H; Duan H; Shao B; Yang F; Li H; Yang P; Zeng Y; Zheng J; Li Y; Hu J; Lin L; Teng L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
